Reaction
Mucous Membrane Disorder reporting signals
As of the last recalculation, Mucous Membrane Disorder appears in 1,373 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is GRANISETRON HYDROCHLORIDE (PRR 30.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Granisetron Hydrochloride | 21 | 30.9 | 31.0 |
| Anti-Thymocyte Globulin (Rabbit) | 14 | 26.6 | 26.6 |
| Dalteparin Sodium | 16 | 23.2 | 23.2 |
| Micafungin Sodium | 11 | 19.8 | 19.8 |
| Salmeterol Xinafoate | 10 | 17.7 | 17.7 |
| Carbamazepine | 70 | 16.6 | 16.7 |
| Melphalan Hydrochloride | 26 | 16.0 | 16.0 |
| Thiotepa | 9 | 14.4 | 14.4 |
| Diphenhydramine Hcl | 10 | 13.7 | 13.7 |
| Granisetron | 9 | 13.1 | 13.1 |
| Melphalan | 18 | 12.1 | 12.2 |
| Gefitinib | 7 | 11.8 | 11.8 |
| Itraconazole | 9 | 11.8 | 11.8 |
| Lamotrigine | 92 | 11.3 | 11.3 |
| Fludarabine Phosphate | 28 | 11.0 | 11.0 |
| Amphotericin B | 9 | 11.0 | 11.0 |
| Piperacillin And Tazobactam | 8 | 9.5 | 9.5 |
| Regorafenib | 7 | 9.2 | 9.2 |
| Doxorubicin Hydrochloride | 18 | 8.5 | 8.5 |
| Fosaprepitant Dimeglumine | 7 | 7.8 | 7.8 |
| Sunitinib Malate | 19 | 7.4 | 7.4 |
| Sorafenib | 10 | 7.3 | 7.3 |
| Pertuzumab | 11 | 6.2 | 6.2 |
| Irinotecan Hydrochloride | 5 | 5.9 | 5.9 |
| Lapatinib | 6 | 5.9 | 5.9 |